Atara Biotherapeutics, Inc. 0HIY.L
0HIY.L
Atara Biotherapeutics, Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0IL8.L
FibroGen, Inc. 0HX7.L
Adicet Bio, Inc. 0JW9.L
Lite Strategy, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0L85.L
Sorrento Therapeutics, Inc. 0HL9.L
Affimed N.V. 0YC0.L
Unity Biotechnology, Inc. 0J4V.L
Heron Therapeutics, Inc.
Atara Biotherapeutics, Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0IL8.L
FibroGen, Inc. 0HX7.L
Adicet Bio, Inc. 0JW9.L
Lite Strategy, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0L85.L
Sorrento Therapeutics, Inc. 0HL9.L
Affimed N.V. 0YC0.L
Unity Biotechnology, Inc. 0J4V.L
Heron Therapeutics, Inc.
Performance
| Periode | 0HIY.L | 0KCC.L | 0IL8.L | 0HX7.L | 0JW9.L | 0H8T.L | 0L85.L | 0HL9.L | 0YC0.L | 0J4V.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 176.75 % | 35.23 % | 45.47 % | 102.02 % | 28.34 % | 62.33 % | 0.00 % | -99.98 % | -93.88 % | -29.23 % |
| YTD | 3.73 % | 64.50 % | -19.96 % | 5.51 % | -14.29 % | -25.87 % | 1 120.00 % | -99.99 % | -94.83 % | -20.55 % |
| 1Y | 85.64 % | 25.41 % | 21.90 % | -27.14 % | -10.11 % | 55.62 % | 408.33 % | -100.00 % | -96.00 % | -26.84 % |
| 3Y | -83.64 % | -75.00 % | -97.20 % | -93.22 % | -66.39 % | -88.54 % | -99.60 % | -100.00 % | -98.50 % | -63.91 % |
| 5Y | -42.35 % | 37.68 % | -97.14 % | -92.51 % | -95.99 % | -73.37 % | -99.94 % | -99.98 % | -99.90 % | -93.85 % |
| 10Y | -33.63 % | 1 776.54 % | -97.14 % | -92.51 % | -94.57 % | -92.32 % | -99.92 % | -99.96 % | -99.96 % | -94.67 % |
| Depuis le début | -33.63 % | 1 776.54 % | -97.14 % | -92.51 % | -94.57 % | -92.32 % | -99.92 % | -99.96 % | -99.96 % | -94.67 % |